Annals of Indian Academy of Neurology
  Users Online: 4310 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size

Table of Contents
LETTER TO THE EDITOR
Year : 2017  |  Volume : 20  |  Issue : 2  |  Page : 166
 

Carbamazepine: A symptomatic treatment of the paresthesiae associated with Lhermitte's sign


Department of Neurology, Karolinska University Hospital, Huddinge, Stockholm, Sweden

Date of Web Publication8-May-2017

Correspondence Address:
Karl Ekbom
Department of Neurology, Karolinska University Hospital, Huddinge, Stockholm
Sweden
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aian.AIAN_21_17

Rights and Permissions

 



How to cite this article:
Ekbom K. Carbamazepine: A symptomatic treatment of the paresthesiae associated with Lhermitte's sign. Ann Indian Acad Neurol 2017;20:166

How to cite this URL:
Ekbom K. Carbamazepine: A symptomatic treatment of the paresthesiae associated with Lhermitte's sign. Ann Indian Acad Neurol [serial online] 2017 [cited 2019 Nov 12];20:166. Available from: http://www.annalsofian.org/text.asp?2017/20/2/166/205763


Sir,

I read with great interest the review article on Lhermitte's sign by Khare and Seth.[1] The sign occurs, inter alia, in multiple sclerosis, in traumatic lesions of the cervical cord, and in subacute combined degeneration. I agree that very few studies are available on Lhermitte's sign and there is need of more research in this particular field. In this current review, treatment with extracranial picotesla range pulsed electromagnetic fields was said to be effective. Neck brace and collar might also be prescribed by physical therapists, and exercises and relaxation technique were claimed to be helpful.

I found that carbamazepine in a rather small dosage had an immediate symptomatic effect on the paresthesiae associated with Lhermitte's sign in three patients with multiple sclerosis.[2] In two of the patients, the symptoms reappeared when the treatment was discontinued. In two cases, the effect of the drug could be reproduced in several short series of treatment and was checked at each examination by letting the patient repeatedly bend his/her head forward in both a recumbent and sitting position. The therapeutic results in my cases resembled those obtained by carbamazepine in connection with the treatment of trigeminal neuralgia and spontaneous paroxysmal symptoms in multiple sclerosis such as painful tonic seizures and paroxysmal dysarthria.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Khare S, Seth D. Lhermitte's Sign: The current status. Ann Indian Acad Neurol 2015;18:154-6.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Ekbom K. Carbamazepine, a new symptomatic treatment for the paraesthesiae associated with Lhermitte's sign. Z Neurol 1971;200:341-4.  Back to cited text no. 2
    




 

Top
Print this article  Email this article

    

 
   Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (253 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1455    
    Printed18    
    Emailed0    
    PDF Downloaded31    
    Comments [Add]    

Recommend this journal